Wednesday, November 11, 2026
ExploreSearch
Via News
Via News Knowledge File

NVIDIA Corporation

organization80% conf.·synced Nov 11, 2026

Technology company specializing in semiconductors and AI chips, IPO in 1999, Taiwan semiconductor dependency

60
sourced metrics
5481
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
168.89USD
Nov 10, 2026reference only
Price 52 Week Low
165.17USD
Nov 10, 2026reference only
Stock Return Ytd
-10.6%
Nov 10, 2026reference only
Market Cap
4087138000000USD
Nov 10, 2026reference only
Price 52 Week High
239.24USD
Nov 10, 2026reference only
Shares Outstanding
24200000000.0shares
May 15, 2026reference only
Gross Profit
61157000000.0USD
Apr 26, 2026reference only
Stockholders Equity
195474000000.0USD
Apr 26, 2026reference only
Net Income
58321000000.0USD
Apr 26, 2026reference only
Total Liabilities
64000000000.0USD
Apr 26, 2026reference only
Operating Income
53536000000.0USD
Apr 26, 2026reference only
Rd Expense
6321000000.0USD
Apr 26, 2026reference only
Total Assets
259474000000.0USD
Apr 26, 2026reference only
Cost Of Revenue
20458000000.0USD
Apr 26, 2026reference only
Operating Cash Flow
50344000000.0USD
Apr 26, 2026reference only
Revenue
81615000000.0USD
Apr 26, 2026reference only
Cash
13237000000.0USD
Apr 26, 2026reference only
Eps
2.39USD_per_share
Apr 26, 2026reference only

Stated objectives

Regain billions of dollars in lost business through China market

source
target: billions stated

Share 15% or more of revenue from China sales with US government

source
target: 15 stated

Commission over 1 million square feet for manufacturing Blackwell chips in Arizona and AI supercomputers in Texas

source
target: 1 million square feet stated

Ramp up mass production of AI supercomputers in Texas by September 2026

source
by 2026-09-01 00:00:00stated

Q4 FY2026 revenue target

source
target: $65.0 billion, plus or minus 2% by 2026-01-25 00:00:00stated

Q4 FY2026 GAAP gross margin target

source
target: 74.8%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Q4 FY2026 non-GAAP gross margin target

source
target: 75.0%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Start shipping H200 chips to China

source
by 2026-02-01 00:00:00stated

Deliver up to 10x reduction in inference token cost compared to Blackwell platform

source
target: 10x stated

Reduce number of GPUs needed to train MoE models by 4x compared to Blackwell

source
target: 4x reduction stated

Relationship graph · 5481 connections

Developed by
1330
Supplies to
909
Competes with
729
Covered by
506
Customer of
424
Employs
320
Invested in
224
Partners with
176

Via News coverage

Memory, Power and Photonics: Micron's Doubled Capex Shows Where the AI Buildup Is Landing
November 5, 2026
The AI Build-Out Is Spreading Beyond Chips: Networking, Physical-World Data and Agent Software All Launched in One Week
October 17, 2026
The Agent Platform Race Is Being Won in the Plumbing: Authorization Deals, Policy Enforcement and the Limits of AI Arithmetic
October 16, 2026
The AI Bottleneck Is Memory and Wiring, Not Just Compute: Micron's Spending Doubled While Nvidia, Bull and GlobalFoundries Chase Supply and Bandwidth
October 14, 2026
The AI chip crunch is a memory story first: Micron's spending has doubled, and Nvidia is co-developing its supply
October 12, 2026
The AI memory squeeze: Micron's spending doubles, chip makers consolidate, and a reversible-computing startup rethinks the transistor
October 8, 2026
Agentic AI Hits the Data Wall: Every Enterprise Wants Agents, but Few Can Feed or Trust Them
October 7, 2026
Every Enterprise Plans AI Agents, but Only About 45% of Company Data Is Ready for Them
October 4, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com